The intensifying attention toward fibrotic pathologies and their complex health consequences has established CTGF inhibitors as pivotal players in therapeutic research and commercial development. CTGF, functioning as a matricellular protein and medically recognized as CCN2, carries out essential functions in tissue modification, fibrotic processes, and healing mechanisms. When produced...